What is King Pharmaceuticals's liabilities held for sale?

King Pharmaceuticals (KG) reported liabilities held for sale of $401K in Q1 2026.

What does liabilities held for sale mean?

Liabilities associated with disposal groups classified as held for sale, presented separately on the balance sheet.

King Pharmaceuticals KG Liabilities held for sale

Liabilities held for sale at other companies

SSR MiningSSRM

$415.71M—

American Coastal Insurance CorporationACIC

$0-100%

ClearfieldCLFD

$0—

Acadia Realty TrustAKR

$161K—

AtkoreATKR

$21.2M—

Tetra TechTTEK

$0—

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's liabilities held for sale.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's liabilities held for sale?: King Pharmaceuticals (KG) reported liabilities held for sale of $401K in Q1 2026.
What does liabilities held for sale mean?: Liabilities associated with disposal groups classified as held for sale, presented separately on the balance sheet.